KEYNOTE-641: Phase III study of pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer

Author:

Graff, Julie N.; Liang, Li Wen; Kim, Jeri; Stenzl, Arnulf

Tübinger Autor(en):

Published in:

Future Oncology (2021), Bd. 17, H. 23, S. 3017-3026

Verlagsangabe:

Future Medicine Ltd

Language:

English

Full text:

ISSN:

1744-8301

DDC Classifikation:

610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)